Evaluation of Intraoperative and early postoperative Growth Hormone Levels for Transsphenoidal Resection in Acromegaly

Evaluation of Intraoperative and early postoperative Growth Hormone Levels for Transsphenoidal Resection in Acromegaly - Evaluation of Intra-operative Growth Hormone for Acromegaly

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41147

Enrollment

Registered

2015-01-13

Start date

2015-03-31

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acromegaly growth hormone producing pituitary adenoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with acromegaly and selected for elective transsphenoidal resection pituitary adenoma in the AMC.

Exclusion criteria

Exclusion criteria: All patients that are selected for elective transsphenoidal pituitary adenoma resection for acromegaly are included. When, after being informed about the research protocol, patients do not wish to participate they will not be included.

Design outcomes

Primary

Measure	Time frame
The acquired growth hormone levels will be compared with the outcome of the OGTT (which is plannend according to current protocol) in order to determine curation. Subsequently the predictive value of peroperative growth hormone levels for curation of acromegaly can be determined.	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results